[Non-differentiated carcinoma with osteoclast-like giant cells of the pancreas].

Ann Pathol

Service d'anatomie et cytologie pathologiques, Hôpital Purpan, Toulouse.

Published: June 2003

We report the case of a 53-year-old man who presented a mass involving the head of the pancreas resulting in isolated jaundice. Histologically, the tumor was an undifferentiated carcinoma with osteoclast-like giant cells of the pancreas. This very rare neoplasm resembles giant cell tumor of bone. An epithelial origin is now established and this tumor has been recently considered as a variant of ductal adenocarcinoma of the pancreas in the last WHO histological classification. The diagnosis requires both morphology and immunohistochemistry. Although the prognosis of these tumors is reported to be poor, our case is unusual because of a favorable outcome without relapse after 2 years.

Download full-text PDF

Source

Publication Analysis

Top Keywords

carcinoma osteoclast-like
8
osteoclast-like giant
8
giant cells
8
[non-differentiated carcinoma
4
cells pancreas]
4
pancreas] report
4
report case
4
case 53-year-old
4
53-year-old man
4
man presented
4

Similar Publications

Histological variants of pancreatic ductal adenocarcinoma: a survival analysis.

Langenbecks Arch Surg

October 2024

Department of Surgery, Clinical Sciences Lund, Lund University, Skåne University Hospital, Lund, SE-221 85, Sweden.

Purpose: Pancreatic ductal adenocarcinoma (PDAC) can be classified into distinct histological subtypes based on the WHO nomenclature. The aim of this study was to compare the prognosis of conventional PDAC (cPDAC) against the other histological variants at the population level.

Methods: The Surveillance, Epidemiology and End Results (SEER) database was used to identify patients with microscopically confirmed PDAC.

View Article and Find Full Text PDF
Article Synopsis
  • Undifferentiated carcinoma (UC) and its variant, UC with osteoclast-like giant cells (UC-OGC), were compared to understand their clinical and multiomic differences, particularly in terms of survival and immunological characteristics.
  • UC-OGC was found to be more resectable and had a significantly longer median overall survival compared to UC (10.8 years vs 0.4 years), even after factoring in surgical resection.
  • Both UC and UC-OGC exhibited increased antigen-presenting cells and decreased regulatory T cells compared to pancreatic ductal adenocarcinoma (PDAC), highlighting a potential avenue for immune-modulating therapies in treating these pancreatic cancer variants.
View Article and Find Full Text PDF
Article Synopsis
  • Undifferentiated carcinoma with osteoclast-like giant cells (UC-OGC) is a rare type of pancreatic ductal adenocarcinoma, making up less than 1% of pancreatic cancers.
  • A case study is discussed involving a 62-year-old woman who experienced epigastric pain and an abdominal mass, prompting further medical evaluation.
  • The diagnosis of UC-OGC reflects the challenges associated with identifying this uncommon and complex form of pancreatic cancer.
View Article and Find Full Text PDF

Breast carcinoma is the most common cancer in women. Nineteen different subtypes of breast carcinomas are recognized in the current WHO classification of breast tumors. Except for these subtypes, there are a number of carcinomas with special morphologic and immunohistochemical features that are not included in the 5th WHO classification, while others are considered special morphologic patterns of invasive breast carcinoma of no special type.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!